Latest / Stuff Mom Never Told You / Could a pill cure obesity?
Transcript
- 0:00Speaker 1: Brought to you by the reinvented two thousand twelve camera.
- 0:03Speaker 1: It's ready. Are you welcome to stuff Mom never told you?
- 0:10Speaker 1: From House stuff Works dot Com. Hello, and welcome to
- 0:17Speaker 1: the podcast. I'm Kristen and I'm Caroline. Caroline. Why don't
- 0:20Speaker 1: we start things off with a bit of news. It's
- 0:24Speaker 1: not new news. I think semi new news. Yeah, may news.
- 0:31Speaker 1: People who don't frequently keep up with the news will
- 0:33Speaker 1: maybe not have heard about it. Yes, news for the
- 0:37Speaker 1: under infum So today we are talking about whether or
- 0:42Speaker 1: not a pill can cure obesity and the quotes obesity
- 0:49Speaker 1: epidemic that has been sweeping the United States because an
- 0:55Speaker 1: FDA advisory committee recently recommended that the agency of not one,
- 1:01Speaker 1: but two anti obesity drugs. Yeah, it starts with q nexa.
- 1:06Speaker 1: Back in February, the committee gave a thumbs up to
- 1:08Speaker 1: that drug, which is made by Vivas or vis It's
- 1:12Speaker 1: a drug company. It's called Vivis. It's pronounced yeah anyway. Uh.
- 1:16Speaker 1: This is also there's Lorca sarin brand name would be Lorkess,
- 1:21Speaker 1: and that is another drug to treat obesity, both of
- 1:25Speaker 1: which had previously been rejected after they submitted studies to
- 1:29Speaker 1: this advisory committee and they were like, no, we're not
- 1:31Speaker 1: convinced that you won't kill people. Yeah. For instance, uh
- 1:35Speaker 1: Lorkes was initially red lighted because the medications seemed to
- 1:41Speaker 1: only provide modest weight loss, and there were also some
- 1:45Speaker 1: studies linking it to mammary tumors in rats, and so
- 1:49Speaker 1: the drug companies went back, they did more studies, they
- 1:52Speaker 1: did more tweaking, and came back again, and the FDA
- 1:56Speaker 1: Advisor Committee is like, all right, you know, put it
- 1:59Speaker 1: through um putting, pushing it closer to getting these drugs
- 2:03Speaker 1: on the market. And just on a side note, just
- 2:08Speaker 1: getting that Advisory committee green light is such a financial
- 2:12Speaker 1: boon for these companies. Um. Right after Lorcas announced that,
- 2:18Speaker 1: or I guess Arena Pharmaceuticals that produced Lorcas announced that
- 2:22Speaker 1: the FDA Advisory Committee Committee had given it the thumbs up,
- 2:25Speaker 1: shares of uh It's stock skyrocket immediately. Well, I mean
- 2:32Speaker 1: I can see that because you know they've been and
- 2:35Speaker 1: we'll get into this, but there have been so many
- 2:38Speaker 1: attempts at successful obesity drugs that help you lose weight
- 2:42Speaker 1: and don't actually weaken your heart. UM, So if there
- 2:45Speaker 1: is something a promising drug to treat an epidemic that
- 2:49Speaker 1: is very widespread that could potentially make a lot of
- 2:52Speaker 1: money for a lot of people. Absolutely, and there's also
- 2:54Speaker 1: the money that goes into all of these clinical trials
- 2:59Speaker 1: that the pharmaceutical companies have to fund. But kind of
- 3:04Speaker 1: in the back of my mind, I'm always a little
- 3:06Speaker 1: wary of all of those hundreds of millions of dollars
- 3:09Speaker 1: that are going into these drugs because of the potential
- 3:12Speaker 1: to earn money. But my skepticism aside um. According to
- 3:20Speaker 1: Forbes Magazine Lord kest and this is now we're talking
- 3:24Speaker 1: in two thousand twelve, not when the FDA UH initially
- 3:28Speaker 1: put the brakes on it. Lorkes helps people lose on
- 3:31Speaker 1: average three percent more weight than diet alone UM and
- 3:36Speaker 1: will also increase the percentage for people who lose five
- 3:39Speaker 1: percent of their body weight. So it seems like there's
- 3:41Speaker 1: kind of a snowball effect there, the more weight that
- 3:43Speaker 1: they're able to lose with medication and UH dietary changes
- 3:48Speaker 1: because doctors always advised that with UM clinically obese people
- 3:52Speaker 1: that they've got to have the it's not just the
- 3:54Speaker 1: magic bill. There has to be nutritional change that goes
- 3:56Speaker 1: along with that, and there is more good news because
- 3:59Speaker 1: the senior VP at Arena, the drug company producing Lorcas,
- 4:03Speaker 1: says that the cancer they found in these studies is
- 4:05Speaker 1: rats specific. But it's not all good news because there
- 4:11Speaker 1: are some people out there's medical experts who still have
- 4:15Speaker 1: concerns about possible heart valve problems. Um, there are calls
- 4:20Speaker 1: for more cardiovascular tests across the board for any kind
- 4:25Speaker 1: of anti obesity drug, probably because of issues with the
- 4:31Speaker 1: now defunct Finfin, which we'll talk about in a minute.
- 4:35Speaker 1: That um initially people got excited about because hey, it's
- 4:39Speaker 1: easy to lose weight, and it's producing all this extra
- 4:41Speaker 1: serotonin in your brain, so you feel good while you're
- 4:43Speaker 1: doing it. But then down the road they were like, wait,
- 4:46Speaker 1: my heart doesn't work quite right. And there are also,
- 4:50Speaker 1: you know, some potential side effects. Were still talking about
- 4:54Speaker 1: uh lord kess of headaches and cognitive problems, like the
- 4:59Speaker 1: potential you for amnesia. But then they might just you know, forget,
- 5:06Speaker 1: forget that they ever had way to know. I'm about
- 5:09Speaker 1: to argue in favor of amnisia. Well, I mean it
- 5:12Speaker 1: sounds like you take a pill and you end up
- 5:14Speaker 1: on a soap opera. Yeah, you end up thin with amnesia. UM.
- 5:19Speaker 1: But yeah, Kristen just mentioned that there are more tests
- 5:22Speaker 1: being called for for these types of medications. And back
- 5:25Speaker 1: in March, an FDA advisory committee voted to require clinical
- 5:29Speaker 1: trials to ensure that obesity drugs do not cause heart attacks.
- 5:33Speaker 1: And this sort of caused an argument because some people
- 5:36Speaker 1: were saying that this would actually discourage people because it's
- 5:39Speaker 1: a very expensive process to go back and do all
- 5:42Speaker 1: these tests over and over again, and a lot of
- 5:45Speaker 1: tests are performed from the beginning anyway, So a lot
- 5:48Speaker 1: of people were saying that this added cost, added time
- 5:51Speaker 1: would discourage people from developing certain obesity drugs. But then
- 5:55Speaker 1: other people are like, hey, shouldn't we air on the
- 5:58Speaker 1: side of caution anyway? I mean, and that's okay. So
- 6:01Speaker 1: we with this issue of whether or not we like
- 6:04Speaker 1: a pill can cure and quotes obesity. Um. There are
- 6:09Speaker 1: two big things to talk about. What a what kind
- 6:11Speaker 1: of problem are we talking about talking about? UM? Like,
- 6:14Speaker 1: what what is the scope of obesity right now? And
- 6:18Speaker 1: what might happen if some kind of medication does not
- 6:22Speaker 1: get on the market that can cause some significant changes? Um?
- 6:27Speaker 1: And also why has it been so difficult to find
- 6:31Speaker 1: some kind of anti obesity medication. So first up, let's
- 6:36Speaker 1: talk about just plain stats on obesity. And we're talking
- 6:39Speaker 1: about the adult population right now. We're not talking about
- 6:42Speaker 1: childhood obesity. Um. Some Duke researchers, this was reported in
- 6:47Speaker 1: Slate in USA today. Some Duke researchers project that the
- 6:50Speaker 1: percentage of Americans who are severely obese, which would be
- 6:53Speaker 1: a hundred or more pounds overweight. I'm sorry for metrics
- 6:59Speaker 1: system listeners right now. I don't don't have that those
- 7:02Speaker 1: that kilogram conversion or stones. I WI should know how
- 7:05Speaker 1: many stones that was. But for severely obased people that
- 7:09Speaker 1: they're projected to nearly double to eleven of the population
- 7:13Speaker 1: by if we continue in the path that we are on,
- 7:17Speaker 1: and they project that of the population may end up
- 7:21Speaker 1: being abased by twenty thirty, which is up from the
- 7:24Speaker 1: rate of thirty six percent. And if we were to
- 7:28Speaker 1: just keep it that level of thirty six percent and
- 7:33Speaker 1: not not hit those those rising levels, just just seeing
- 7:36Speaker 1: plateaued right where we are. The Duke study co author
- 7:40Speaker 1: Justin Shrogden says that the United States alone would save
- 7:44Speaker 1: more than five hundred and forty nine point five billion
- 7:48Speaker 1: dollars in weight related medical expenditures through twenty thirties. Insane.
- 7:53Speaker 1: And just on another side note, since we're talking about
- 7:56Speaker 1: billions of dollars, the US weight loss industry is now
- 7:59Speaker 1: s made it roughly sixty billion dollars. There's so much
- 8:03Speaker 1: money everywhere in this conversation. There is a people are
- 8:06Speaker 1: willing to do almost anything to lose weight except sometimes
- 8:10Speaker 1: work out. Yes, um, but that's okay. Uh. The projected
- 8:16Speaker 1: increased rate of obesity, this whole thing with the Duke research,
- 8:20Speaker 1: that means that thirty two million more obese people will
- 8:24Speaker 1: show up within two decades show up to the party. Yeah,
- 8:28Speaker 1: and um. The Duke researchers were trying to figure out
- 8:32Speaker 1: the factors that might be going into this forecasting, and
- 8:37Speaker 1: they're looking at things like the unemployment rate, prices of
- 8:40Speaker 1: fast food, alcohol, and fuel. And if you're thinking about
- 8:43Speaker 1: the price of fuel, that ties into the sedentary culture
- 8:48Speaker 1: that we live in right now. I mean, I just
- 8:51Speaker 1: thinking about myself, Like I take public transit to work
- 8:54Speaker 1: and I still sit constantly. I actually took public transit
- 8:58Speaker 1: yesterday and had a woman lying on me on us
- 9:00Speaker 1: So I'm sorry that was me. I was tired, I
- 9:05Speaker 1: was standing, So it's pretty impressive. It's also my yoga.
- 9:11Speaker 1: Um well, I think it is important to ask the
- 9:13Speaker 1: question of how how accurate are these projections, and Slate
- 9:17Speaker 1: did ask that question. Um, they might be a little high,
- 9:20Speaker 1: but they're they're actually pretty accurate. Scarily enough, they point
- 9:24Speaker 1: out that in two thousand three, the CDC predicted that
- 9:27Speaker 1: the rate of obesity would be Americans and that was
- 9:32Speaker 1: pretty close to the actual rate of thirty five point seven.
- 9:36Speaker 1: And we do have to take into account that forecasting
- 9:38Speaker 1: like this hasn't been around forever. It's not like we've
- 9:40Speaker 1: been tracking obesity rates and predicting them for more than
- 9:43Speaker 1: just about a decade. Yeah, which is surprising, because we
- 9:46Speaker 1: hear about obesity and just wait in general all the time.
- 9:50Speaker 1: I feel like we're constantly inundated with information about how
- 9:54Speaker 1: to either how we're getting fatter or how to lose
- 9:57Speaker 1: all of that fats one or the other. Um. And
- 10:00Speaker 1: but it really hasn't been around that long, because it
- 10:03Speaker 1: was only in n that the Institute of Medicine published
- 10:08Speaker 1: a study saying that obesity should be perceived as a
- 10:10Speaker 1: chronic condition like hypertension and recommended that doctors use extended
- 10:15Speaker 1: drug therapy or surgery to treat it. It was a
- 10:18Speaker 1: complete shift in mindset from just saying, hey, you know
- 10:21Speaker 1: you should just go you know, diet exercise to actually
- 10:24Speaker 1: uh pathologizing weight UM and Scientific American looked into why
- 10:34Speaker 1: in that time, from when we have that shift in
- 10:37Speaker 1: the medical community and the perception of obesity and then
- 10:41Speaker 1: the rising rate of obesity UM just to give you
- 10:44Speaker 1: an idea, the rates of obesity were stable from around
- 10:50Speaker 1: the population and then jumped in the nineteen eighties and
- 10:54Speaker 1: nineties and in two thousand and Meanwhile, doctors have tried
- 11:00Speaker 1: to develop some kind of anti obesity drugs, but it
- 11:03Speaker 1: has not been an easy thing to do. No, definitely
- 11:06Speaker 1: not so. In two thousand four Cornell University study looked
- 11:10Speaker 1: at obesity drugs their success, who is using them, And
- 11:13Speaker 1: they looked at nine f d A approved obesity treatment
- 11:16Speaker 1: drugs in particular that were around between and two thousand one,
- 11:21Speaker 1: and those were at apex tenuate at a post did
- 11:25Speaker 1: drex Or directs. I don't know, these names are getting
- 11:27Speaker 1: still a mazanor, pon, demon redux, Meridia, and zenecalo that
- 11:33Speaker 1: got easier to resent and if those don't ring many
- 11:36Speaker 1: bells for listeners. That's because I think Xenical is the
- 11:40Speaker 1: only one of these drugs that you can even still purchase. Yeah, exactly. Um,
- 11:46Speaker 1: they they tended to have quite a few side effects,
- 11:50Speaker 1: and least of which was losing weight. Yes, yes, there
- 11:54Speaker 1: was no significant weight loss with many of these. Um,
- 11:58Speaker 1: they definitely worked to suppress appetite, but they also tended,
- 12:01Speaker 1: you know, to kind of modify your central nervous system neurotransmission.
- 12:06Speaker 1: So the side effects could definitely be fatal in some
- 12:10Speaker 1: instances and could have crazy things happen your heart, your
- 12:14Speaker 1: your mood, your memory, all sorts of things. And so
- 12:17Speaker 1: there's fin fin which we should talk about, which my
- 12:21Speaker 1: mother actually took Finfinn, and let me just tell you
- 12:24Speaker 1: how upset she was. Not about the news about the heart.
- 12:27Speaker 1: She was just really angry. She had to stop taking,
- 12:30Speaker 1: probably because she was going to have a serotonin come down.
- 12:33Speaker 1: But tell, tell the people, tell the kind of people
- 12:35Speaker 1: out there about the heart valve. Yeah, fin Finn was
- 12:38Speaker 1: pulled from the market in nineties seven because it damaged
- 12:41Speaker 1: heart valves, which we've mentioned is a side effect of
- 12:43Speaker 1: some of these things, and it was a combination of
- 12:46Speaker 1: pondamin or fin fluoramine, which releases extra serotonin, like Kristen said,
- 12:52Speaker 1: and the stimulant finn termine. So you you've kind of
- 12:56Speaker 1: got some ups and downs going here. Yeah. It was
- 12:58Speaker 1: essentially like a drug cocktail, an OTC cocktail, over the
- 13:03Speaker 1: counter cocktail that doctors like, oh, hey, here we go,
- 13:06Speaker 1: we can just balance these scales and just lose that weight.
- 13:10Speaker 1: But apparently it was tougher on the heart and the
- 13:13Speaker 1: pharmaceutical company has since had to pay lots of money
- 13:17Speaker 1: to folks for very expensive surgeries. Yeah. Well, the same
- 13:21Speaker 1: year that Finfinn was yanked off the market and Meridia launched,
- 13:24Speaker 1: and it was effective in weight loss, pretty effective. Forty
- 13:27Speaker 1: six percent of people lost ten percent or more of
- 13:30Speaker 1: their body weight and clinical trials, which is significantly more
- 13:32Speaker 1: than what we cited for larks over here, which was
- 13:36Speaker 1: three percent and five percent um. But it affected the
- 13:39Speaker 1: heart rate and was withdrawn in And now it's starting
- 13:43Speaker 1: to make sense why, uh, these medical experts have recently
- 13:48Speaker 1: come out saying, hey, we need cardiovascular tests. They must
- 13:51Speaker 1: be rigorous because all of these uh former ANTIBC drugs
- 13:56Speaker 1: and it being pulled because of heart related issues. And
- 13:59Speaker 1: then we have zen accou, which Kristen points out points
- 14:01Speaker 1: out as one of the few names that I actually
- 14:04Speaker 1: recognized that launched and happy not insignificant side effects of
- 14:10Speaker 1: oily stools and flatulence. So God help you. If you
- 14:14Speaker 1: were taking zenacal and eating a lustrac chips, well that's
- 14:17Speaker 1: the thing. Uh, If you regulated your diet, had a
- 14:22Speaker 1: very low fat diet and seneca, you'd be fine. But
- 14:25Speaker 1: if you decided to blurge and have a parfit or
- 14:31Speaker 1: some French fries, then you'd have a Well you have
- 14:35Speaker 1: oily stools. I'll just leave it at that, right, Well,
- 14:37Speaker 1: that's because your body isn't absorbing it or or digesting it.
- 14:41Speaker 1: It's just passing. The fat is just passing right through you.
- 14:44Speaker 1: And I'm glad you mentioned o Leustra chips because front
- 14:48Speaker 1: Line over PBS I didn't end that story on the
- 14:53Speaker 1: fen Fenn craze. And essentially, how you know we have
- 14:59Speaker 1: you know, the studies coming out saying that we need
- 15:01Speaker 1: to treat obesity. Obesity is becoming a problem and people
- 15:04Speaker 1: start getting aware of it, and we want to lose
- 15:07Speaker 1: this weight. And by we, I mean I'm talking more
- 15:09Speaker 1: specifically about Americans, but we don't really want to change
- 15:12Speaker 1: our lifestyles necessarily, and so you have all of a
- 15:17Speaker 1: sudden this bonanza of low fat junk food. This is
- 15:22Speaker 1: when brands like snack Wells come up and make bookoos
- 15:25Speaker 1: of money because you can still ey cookies because they're
- 15:27Speaker 1: just fat free. Or my favorite product, which I remember
- 15:32Speaker 1: when it first came out, I was I was pretty
- 15:35Speaker 1: pumped about it because I liked potato chips, but it
- 15:37Speaker 1: was those o Lustri chips which really did taste like
- 15:41Speaker 1: normal potato chips, but they were fat free. Um. But
- 15:44Speaker 1: if you ate too many, you would be on the
- 15:46Speaker 1: toilet for quite a while because those that's just a
- 15:50Speaker 1: load right through well. We we had all of that
- 15:53Speaker 1: stuff in my house because my dad had a heart attack.
- 15:57Speaker 1: So that's like right at the peak of all this
- 15:59Speaker 1: healthy junk food coming out, and it's like, I know,
- 16:02Speaker 1: it's it's really hard. Dieting is a lifestyle change, and
- 16:05Speaker 1: it's hard to all of a sudden go from you know,
- 16:08Speaker 1: eating kind of tasty junk food too, being told you
- 16:11Speaker 1: need to just stick to fruits and vegetables basically, So
- 16:14Speaker 1: we those weird snack foods definitely aided his transition. And
- 16:18Speaker 1: also we have to you know, acknowledge things like thyroid
- 16:21Speaker 1: problems and other genetic problems that might make it harder
- 16:24Speaker 1: for you to lose weight or impossible for you to
- 16:27Speaker 1: lose weight. And if we're talking about obesity as well,
- 16:29Speaker 1: the it's not a snap of the fingers hop on
- 16:31Speaker 1: a treadmill, because you know, there are health problems that
- 16:35Speaker 1: could or health risks that could even go along with
- 16:38Speaker 1: intensive exercise. So the you know, plenty of doctors have
- 16:42Speaker 1: stressed the need for some kind of anti obesity drug,
- 16:46Speaker 1: which does seem like a much better alternative to poop
- 16:49Speaker 1: chip um exactly. Um. But this Cornell study looked at
- 16:57Speaker 1: who exactly is taking this medicine, and it's kind of
- 17:01Speaker 1: surprising because basically they found that the people who really
- 17:03Speaker 1: should be taking it, the severely obese population, only one
- 17:08Speaker 1: of those people who meet the medical criteria are taking
- 17:12Speaker 1: the medicine. Of those taking anti obesity drugs don't meet
- 17:16Speaker 1: the medical criteria for their use. So that means that
- 17:19Speaker 1: for every two point to nine people, so like two
- 17:22Speaker 1: tall people and a short person maybe taking for every
- 17:26Speaker 1: two point to nine people taking such a drug who
- 17:28Speaker 1: meet the criteria, another person using it doesn't And we
- 17:32Speaker 1: should also emphasize we probably should have said this earlier
- 17:34Speaker 1: in the podcast. We're talking specifically about prescription anti obesity pills,
- 17:39Speaker 1: not over the counter pills. If you are, you know,
- 17:44Speaker 1: trying to drop a few pounds before um, I don't know,
- 17:49Speaker 1: uh sure. And we should also say too that the
- 17:54Speaker 1: Cornell study pointed out that whether or not someone has
- 17:58Speaker 1: prescription drug coverage with health care insurance will also make
- 18:02Speaker 1: a difference, because those who do are fifty seven percent
- 18:06Speaker 1: more likely than those without coverage to use anti obesity drugs.
- 18:09Speaker 1: Because I can imagine if these are you know, there
- 18:13Speaker 1: are not generics of these kinds of drugs, and they're
- 18:15Speaker 1: probably pretty expensive. So we haven't talked about gender yet
- 18:20Speaker 1: in the podcast, but if we're talking about weight loss,
- 18:24Speaker 1: as you can imagine, there is plenty of gender information
- 18:28Speaker 1: out there. Yeah. According to the National Health and Nutrition
- 18:31Speaker 1: Examination Study from in two thousand, more men than women
- 18:36Speaker 1: were overweight or obese. Um, but it looks like more
- 18:41Speaker 1: women are actually taking these prescription anti obesity drugs. Once again,
- 18:46Speaker 1: signing that Cornell study from two thousand, four, women are
- 18:50Speaker 1: how about this A hundred and eighty one cent more
- 18:53Speaker 1: likely to use anti obesity drugs, and it is probably
- 18:57Speaker 1: because women tend to be more motivate aded to lose
- 19:01Speaker 1: weight than men are, because well, hey, we've talked about
- 19:06Speaker 1: before in the podcast, how physiologically it is harder for
- 19:10Speaker 1: women to lose weight. Men can drop pounds quicker because
- 19:14Speaker 1: of the muscle mass, et cetera. Um. According to a
- 19:17Speaker 1: two thousand eleven gallop pole, sevent of American women have
- 19:23Speaker 1: attempted to lose weight an average of seven times, compared
- 19:27Speaker 1: to fifty of men who have attempted to lose weight
- 19:30Speaker 1: an average of four times. It's they that's a huge gap.
- 19:34Speaker 1: It is a huge gap. And yet women are actually
- 19:36Speaker 1: less likely, according to that galop Pole, to cite exercise
- 19:41Speaker 1: as helping them lose weight. In the poop chips, God,
- 19:45Speaker 1: you've God, he brought up a lestra I did it
- 19:50Speaker 1: is my fault that you called them poop chips? Um.
- 19:53Speaker 1: There are other factors that Cornell looked at in looking
- 19:57Speaker 1: at who is taking these prescription obesity draw um. They
- 20:01Speaker 1: controlled for whether the survey respondents met the medical criteria
- 20:04Speaker 1: for using these drugs and found that African Americans were
- 20:07Speaker 1: only as likely as whites to use them. Yeah, and
- 20:12Speaker 1: with Hispanics there were only seventy as likely as whites
- 20:15Speaker 1: to use the drugs. So even if let's say those
- 20:18Speaker 1: two drugs we talked about at the top of the podcast,
- 20:21Speaker 1: Lorcus and Quenexa get the green light, they end up
- 20:24Speaker 1: on the market, the question is going to be whether
- 20:26Speaker 1: or not they actually get into the hands of the
- 20:29Speaker 1: population that medically could benefit from them. So that's a
- 20:36Speaker 1: big question that we've got to ask um. And also
- 20:39Speaker 1: in the meantime, there are all these over the counter
- 20:43Speaker 1: diet pills that I'm sure everyone is seen in drug
- 20:47Speaker 1: stores or on advertisements promising to lose weight quickly. And
- 20:53Speaker 1: we don't need to go to in depth on it
- 20:55Speaker 1: except to say that really take the well, don't take him.
- 21:00Speaker 1: But I'm saying take the advertisements with a grain of salt. Yeah,
- 21:05Speaker 1: And like in h for Ally for instance, that over
- 21:08Speaker 1: the counter diet pill, they encourage you in the ad
- 21:12Speaker 1: to make it part of a healthy diet and exercise
- 21:16Speaker 1: because you know, we've already talked about the poop chips.
- 21:19Speaker 1: Ally is just or Lesstat all over again, but it's
- 21:23Speaker 1: in a reduced strength version. And so the Mayo Clinic
- 21:26Speaker 1: basically tells you that bowel changes will result from the
- 21:30Speaker 1: undigested fat moving through your system, So eat that low
- 21:33Speaker 1: fat diet. If you're taking an over the counter pill
- 21:35Speaker 1: like ally, because it ends up decreasing the absorption of
- 21:38Speaker 1: some vitamins. Yeah, yeah, so you'll need to take those
- 21:41Speaker 1: supplements um as well. And of course the Mayo Clinic
- 21:43Speaker 1: urges you to talk to your doctor first. And remember
- 21:46Speaker 1: there are no quick fixes when it comes to popping
- 21:49Speaker 1: a pill to lose some weight. Generally, the first course
- 21:53Speaker 1: of action is changing the diet and exercise. With all
- 21:55Speaker 1: of these drugs that we have talked about, there's repeated
- 21:59Speaker 1: mention of the prescription along with the nutritional counseling to
- 22:05Speaker 1: make sure that you're eating more healthily. And who's to
- 22:08Speaker 1: say that in the future we won't have a really
- 22:09Speaker 1: successful diet drug, one that doesn't cause hard problems, helps
- 22:12Speaker 1: you lose weight, and doesn't make you poop all the time. Um.
- 22:16Speaker 1: Scientific American actually pointed out that obesity drugs in the
- 22:19Speaker 1: future could be a replacement for weight loss surgery, which,
- 22:22Speaker 1: although it is successful for a lot of people, it
- 22:23Speaker 1: is pretty dangerous. So if we end up with a
- 22:26Speaker 1: really good, successful relatively healthy diet drug, anti obesity drug.
- 22:32Speaker 1: You know, maybe that could help with the surgery stuff. Yeah,
- 22:34Speaker 1: I mean it seems like from what the doctors who
- 22:37Speaker 1: are seeing all of these patients are saying, yes, we
- 22:40Speaker 1: need some kind of medical treatment, and you know too,
- 22:45Speaker 1: as an alternative to something like gastric bypass surgery. But uh,
- 22:50Speaker 1: it's it's hard to figure out how to do that
- 22:52Speaker 1: without endangering our hearts and our brains and our bodies.
- 22:59Speaker 1: So with at first of all, I apologize to listeners
- 23:03Speaker 1: for the excessive use of the phrase poop chips, and
- 23:07Speaker 1: I think I deserve an apology. And I apologize to
- 23:10Speaker 1: Caroline uh, and I will not ask for your for
- 23:14Speaker 1: your feedback. What do you think about, um, these anti
- 23:18Speaker 1: obesity drugs. Do you think the FDA should be more careful?
- 23:20Speaker 1: Do you think that they should actually speed up the
- 23:22Speaker 1: process get these things on the market? Um, and also
- 23:26Speaker 1: advertisements for over the counter diet pills, stuff like that.
- 23:31Speaker 1: I don't know. Let us know your thoughts, mom. Stuff
- 23:33Speaker 1: at Discovery dot com is where you can send your letters.
- 23:36Speaker 1: And the meantime, we've got a couple here from some
- 23:39Speaker 1: older episodes. My first email here from Nicole is in
- 23:47Speaker 1: regard to our long ago podcast on gender segregated education.
- 23:54Speaker 1: She writes, I went to an all girls Catholic high
- 23:56Speaker 1: school at that age. Being in an all girls class
- 23:59Speaker 1: was great, mostly because I was so shy. It really
- 24:01Speaker 1: helped me build confidence. Plus there were less distractions in
- 24:04Speaker 1: the classroom. We never had much trouble finding dates. You
- 24:08Speaker 1: guys mentioned that girls may be more awkward around guys
- 24:11Speaker 1: since they wouldn't have as much experience socializing with them.
- 24:14Speaker 1: Totally not true. After high school, I went to college
- 24:17Speaker 1: to get a degree in civil engineering, so I had
- 24:19Speaker 1: class with a lot of guys, and almost all of
- 24:21Speaker 1: my professors were guys. Sometimes I was the only girl
- 24:24Speaker 1: in class, but I got used to it very quickly
- 24:26Speaker 1: and it wasn't too awkward. It was actually quite nice
- 24:29Speaker 1: since you're the only girl the guys sent to remember
- 24:31Speaker 1: you so occasionally. At a house party, I got to
- 24:34Speaker 1: cut the kegline and even scored a few free beers
- 24:37Speaker 1: at the bar. My housemates were a little jealous that
- 24:40Speaker 1: the nerdy girl knew so many guys. It's always nice
- 24:45Speaker 1: to cut a kegline, That's what I always say. Uh.
- 24:49Speaker 1: This is an email from Hannah about the Midwife episode.
- 24:52Speaker 1: She said, I just finished listening to your episode on
- 24:54Speaker 1: dulas and midwives and thought i'd pipe in with my story,
- 24:57Speaker 1: even if I'm a year late. I gave birth eight
- 25:00Speaker 1: months ago and had both a midwife and a dulah.
- 25:02Speaker 1: I also delivered at a birthing center, and I can
- 25:04Speaker 1: say from experience that having both was the most important
- 25:07Speaker 1: thing I ever did. I am considered low income, and
- 25:09Speaker 1: my dula decided to provide her services free of charge,
- 25:12Speaker 1: and it was because of her that I had an
- 25:13Speaker 1: unmedicated i e. Natural birth. This woman had no pain
- 25:17Speaker 1: killers at the times when I was overcome. It was
- 25:20Speaker 1: her soothing voice that kept me going. After I gave birth,
- 25:23Speaker 1: there were some complications. I had hemorrhaging. My midwife not
- 25:26Speaker 1: only kept a cool head, but also didn't just wait
- 25:28Speaker 1: around until the medics came. She acted quickly and ended
- 25:30Speaker 1: up saving my life. However, when I was transferred to
- 25:33Speaker 1: the hospital, my midwife was able to stay, my dulah
- 25:36Speaker 1: was told she had to leave. I was pretty out
- 25:38Speaker 1: of it at the time, so I didn't know what
- 25:39Speaker 1: was going on. After I came out of my days,
- 25:41Speaker 1: I was so furious that a hospital which claims to
- 25:44Speaker 1: be very woman centered with the best of start tricks around.
- 25:47Speaker 1: Didn't have enough respect to allow my Duelah to stay.
- 25:50Speaker 1: Perhaps Duela's are seen is pushy and nonconformist, but mine
- 25:53Speaker 1: isn't and is the sweetest, most gentle woman I know.
- 25:56Speaker 1: We are still in contact and I count her as
- 25:58Speaker 1: a friend. So thanks to everybody who's written in. Mom
- 26:02Speaker 1: Stuff at Discovery dot Com is where you can send
- 26:04Speaker 1: your letters. You can also find us on Facebook and
- 26:08Speaker 1: follow us on Twitter at mom Stuff Podcast, and if
- 26:12Speaker 1: you would like to see what we're up to during
- 26:13Speaker 1: the week, you can head over to our website, It's
- 26:15Speaker 1: how Stuff works dot com for more on this and
- 26:21Speaker 1: thousands of other topics. Is it how stuff works dot
- 26:24Speaker 1: com brought to you by the reinvented two thousand twelve camera.
- 26:32Speaker 1: It's ready, are you